摘要
目的了解医院重症监护病房及有关病房住院患者鲍曼不动杆菌感染的现状及其耐药性,为临床合理选用抗菌药物提供依据。方法采用细菌分离鉴定技术和药敏试验方法,对某医院部分病房住院患者鲍曼不动杆菌感染及其耐药性进行了监测。结果重症监护病房患者感染标本中鲍曼不动杆菌的分离率为17.2%,普通病房住院患者感染标本的分离率为6.0%。临床分离的鲍曼不动杆菌对常用抗菌药物耐药性严重,仅对多粘菌素E、亚胺培南、美罗培南和阿米卡星相对敏感。结论重症监护病房患者标本中鲍曼不动杆菌的检出率明显高于普通病房,临床分离鲍曼不动杆菌耐药性严重。
Objective To investigate the present situation of infection and drug resistance of Acinetobacter baumannii in ICU and the general ward, so as to guide the application of antibiotics. Methods The bacterial culture method of identification and drug sensitivity test were used to investigate the present situation of infection and drug resistance of Acinetobacter baumannii in hospital patients. Results The Acinetobacter baumannii isolation rates of the inpatients of ICU and the general ward were 17.2% and 6.0% respectively. The Acinetobacter baumannii of clinical isolation strains had very serious drug resistance and was only relatively sensitive to Plymyxin E, Imipenem, Meropenem and Amikacin. Conclusion The Acine- tobacter baumannii detection rate of ICU patient specimens is significantly higher than that of the general wards. The clini- cal isolates of Acinetobacter baumannii has serious resistance.
出处
《中国消毒学杂志》
CAS
北大核心
2013年第10期923-924,927,共3页
Chinese Journal of Disinfection
